Author Page for Jos H. Beijnen

Development and Validation of an Lc-Ms/Ms Method For Simultaneous Quantification of 8 Drugs in Plasma and Brain

Number of pages: 25 Posted: 25 Jun 2024

Aristeidis Lentzas, Nikkie Venekamp, Jos H. Beijnen and Olaf van Tellingen

affiliation not provided to SSRN, affiliation not provided to SSRN, Utrecht University and Netherlands Cancer Institute - Mouse Clinic for Cancer and Aging (MCCA)

Downloads 88 (759,537)

Citation 1

Abstract:

2.

Development and Validation of a High-Performance Liquid Chromatography Tandem Mass Spectrometry Method for the Quantification of the Antiparasitic and Antifungal Drug Amphotericin B in Human Skin Tissue

Number of pages: 19 Posted: 26 Apr 2022

Ignace Roseboom, Bas Thijssen, Hilde Rosing, Fabiana Alves, Shyam Sundar, Jos H. Beijnen and Thomas P.C. Dorlo

Netherlands Cancer Institute Antoni van Leeuwenhoek, affiliation not provided to SSRN, Netherlands Cancer Institute Antoni van Leeuwenhoek, Drugs for Neglected Diseases Initiative (DNDi), Banaras Hindu University (BHU) - Institute of Medical Sciences (IMS), Utrecht University and affiliation not provided to SSRN

Downloads 78 (823,616)

Abstract:

3.

Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of the Antimalarial Drug Pyronaridine in Human Whole Blood

Number of pages: 23 Posted: 31 Jan 2024

Wietse M. Schouten, Ignace Roseboom, Luc Lucas, Japhet Kabalu Tshiongo, Hypolite Muhindo Mavoko, Kassoum Kayentao, Hilde Rosing, Alwin Huitema, Jos H. Beijnen and Thomas P.C. Dorlo

Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Université de Kinshasa, Université de Kinshasa, University of Sciences, Technique and Technologies of Bamako (USTTB), Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Utrecht University and Uppsala University

Downloads 57 (1,020,567)

Abstract:

4.

Development and Validation of an LC-MS/MS Assay for the Quantification of Cintirorgon (LYC-55716) in Mouse Plasma and Tissue Homogenates

Number of pages: 29 Posted: 01 Jul 2021

Paniz Heydari, Wenlong Li, Alfred H. Schinkel, Jos H. Beijnen and Rolf W. Sparidans

Utrecht University, Utrecht University, Netherlands Cancer Institute, Utrecht University and Utrecht University

Downloads 48 (1,086,013)

Abstract:

5.

Development of a Uplc-Ms/Ms Assay for the Quantitative Determination of Capecitabine, 5’-Deoxy-5-Fluorocytidine (5’-Dfcr), 5’-Deoxy-5-Fluorouridine (5’-Dfur), 5’-Fluorouracil (5-Fu), and Α-Fluoro-Β-Alanine (Fbal)

Number of pages: 17 Posted: 18 Aug 2022

Jonathan Emanuel Knikman, Niels de Vries, Hilde Rosing, Annemieke Cats, Henk-Jan Guchelaar and Jos H. Beijnen

affiliation not provided to SSRN, affiliation not provided to SSRN, Netherlands Cancer Institute Antoni van Leeuwenhoek, affiliation not provided to SSRN, Leiden University - Department of Clinical Pharmacy and Toxicology and Utrecht University

Downloads 41 (1,170,409)

Jos H. Beijnen

Utrecht University

5

312

1

Scholarly Papers (5)

Development and Validation of an Lc-Ms/Ms Method For Simultaneous Quantification of 8 Drugs in Plasma and Brain

Abstract:

Development and Validation of a High-Performance Liquid Chromatography Tandem Mass Spectrometry Method for the Quantification of the Antiparasitic and Antifungal Drug Amphotericin B in Human Skin Tissue

Abstract:

Development and Validation of an Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Method for the Quantification of the Antimalarial Drug Pyronaridine in Human Whole Blood

Abstract:

Development and Validation of an LC-MS/MS Assay for the Quantification of Cintirorgon (LYC-55716) in Mouse Plasma and Tissue Homogenates

Abstract:

Development of a Uplc-Ms/Ms Assay for the Quantitative Determination of Capecitabine, 5’-Deoxy-5-Fluorocytidine (5’-Dfcr), 5’-Deoxy-5-Fluorouridine (5’-Dfur), 5’-Fluorouracil (5-Fu), and Α-Fluoro-Β-Alanine (Fbal)

Abstract: